2 Vaccine Stocks to Buy on Concerns About the Omicron Covid Variant -Breaking
[ad_1]

The new coronavirus strain omicron, which is highly dangerous, has attracted significant investor attention. We believe that prominent vaccine stocks will continue to be a major source of investor attention, even though researchers still struggle with understanding the effectiveness of the new vaccine. Pfizer BioNTech and BioFed (BNTX) might rally over the next months. Keep reading. These data show that Omicron has several new characteristics that may affect its behaviour. After a few patients began exhibiting unusual symptoms that differ slightly from those associated with the Delta variant, the WHO warned that this variant poses a “very high” global risk and could have “severe consequences for some areas.”
Omicron is home to more than 30 mutations of its spike protein. Therefore, the efficacy of current vaccines could be less. South African scientists are currently investigating omicron. A number of vaccine manufacturers have begun to develop boosters for the Omicron variant. It is possible that a new vaccine targeting omicron could soon be available.
We believe that fundamentally sound stocks like Pfizer Inc. (NYSE) and BioNTech Se (NASDAQ:), could prove to be good investments now.
Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.
[ad_2]